Next Biomedical Co., Ltd.   Report issue

For profit
Founded: Songdomirae-ro Korea, Republic of (2014)

Organization Overview

First Clinical Trial
2016
NCT02978391
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Active Ingredients

Drugs in Other Trials (1)

epinephrine (levophed) (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 1
  • # of Trial APIs: 1